SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001746473-24-000088
Filing Date
2024-06-17
Accepted
2024-06-17 19:52:27
Documents
2
Period of Report
2024-06-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1718668339.html 3  
1 FORM 3 wk-form3_1718668339.xml 3 1613
2 EX-24 limitedpoa.txt EX-24 4349
  Complete submission text file 0001746473-24-000088.txt   7389
Mailing Address 863 MITTEN ROAD, SUITE 102 BURLINGAME CA 94010
Business Address
Krognes Steve E. (Reporting) CIK: 0001666236 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39303 | Film No.: 241049828

Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Issuer) CIK: 0001746473 (see all company filings)

IRS No.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)